[144] Mind Medicine (MindMed) Inc. SEC Filing

Rhea-AI Filing Summary

Mind Medicine (MindMed) Inc. (MNMD) has filed a Form 144, signaling the planned sale of 26,491 common shares. The shares—acquired on 06/25/2025 through the vesting of restricted stock granted under a company plan—are to be sold through Morgan Stanley Smith Barney LLC. Based on an aggregate market value of $180,210.33, the filing values the shares at roughly $6.80 each.

The proposed sale represents a de-minimis 0.035 % of the company’s 75,553,266 shares outstanding and is scheduled to occur on or after 06/25/2025 on the NASDAQ. No additional share sales by the same party were reported for the past three months, and no material adverse information is claimed by the seller in accordance with Rule 144 representations.

Because Form 144 filings merely notify the market of an intent to sell and do not guarantee execution, the practical impact is usually limited unless the size is significant or the seller is a key insider. Given the relatively small volume and lack of prior sales, this notice appears routine and unlikely to materially affect MNMD’s float or share-price dynamics.

Positive

• Transparent disclosure of intended sale via Form 144 maintains regulatory compliance and informs investors.
• Sale size is immaterial at only 0.035 % of shares outstanding, limiting dilution or price pressure concerns.

Negative

• Insider selling, even if small, can be perceived negatively by some investors as a lack of confidence.

Insights

Securities Analyst

TL;DR: Routine Form 144 for 26.5k shares (~$180k); negligible 0.035 % of float—limited market impact expected.

The filing alerts investors that an affiliate intends to dispose of 26,491 MNMD shares. With outstanding shares exceeding 75 million, dilution or float pressure is immaterial. The sale is tied to a restricted-stock vesting event—common for employee compensation. No clustered insider selling or negative disclosures accompany the notice, and no prior 3-month sales were reported. Overall, the transaction looks like standard liquidity management rather than a bearish signal.

Corporate Governance Expert

TL;DR: Insider liquidity event via registered plan; governance implications minimal, transparency intact.

Form 144 filings ensure compliance with Rule 144 resale restrictions. The seller affirms no undisclosed adverse information. The modest size, together with timely disclosure and use of a major brokerage, points to good governance practice. Investors should monitor cumulative insider activity, but this single, small sale does not raise red flags.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	26491	180210.33	75553266	06/25/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/25/2025	Restricted stock vesting under a registered plan	Issuer			26491	06/25/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many MindMed (MNMD) shares are being sold according to the Form 144?

The filing covers 26,491 common shares.

What is the total market value of the shares in this Form 144 filing?

The aggregate market value is $180,210.33.

What percentage of MindMed’s outstanding shares does the sale represent?

Approximately 0.035 % of the 75,553,266 shares outstanding.

When is the planned sale date for these MNMD shares?

The approximate sale date listed is 06/25/2025.

Were any other shares sold by this insider in the past three months?

No. The Form 144 states “Nothing to Report” for prior 3-month sales.